Article Versions Notes

Dötzer K, Schlüter F, Koch FEv, Brambs CE, Anthuber S, Frangini S, Czogalla B, Burges A, Werner J, Mahner S, et al. Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer. Biomedicines. 2021; 9(3):289. https://doi.org/10.3390/biomedicines9030289

Dötzer, Katharina, Friederike Schlüter, Franz Edler von Koch, Christine E. Brambs, Sabine Anthuber, Sergio Frangini, Bastian Czogalla, Alexander Burges, Jens Werner, Sven Mahner, and et al. 2021. "Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer" Biomedicines 9, no. 3: 289. https://doi.org/10.3390/biomedicines9030289

Dötzer, K., Schlüter, F., Koch, F. E. v., Brambs, C. E., Anthuber, S., Frangini, S., Czogalla, B., Burges, A., Werner, J., Mahner, S., & Mayer, B. (2021). Integrin α2β1 Represents a Prognostic and Predictive Biomarker in Primary Ovarian Cancer. Biomedicines, 9(3), 289. https://doi.org/10.3390/biomedicines9030289